Effect of miR-515-5p on Proliferation and Drug Sensitivity of Retinoblastoma Cells
Authors:
Open Access
- 1 November 2020
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 12087-12098
Abstract
Background: Retinoblastoma (RB) is a common malignancy in children eyes. Aberrant microRNA (miR) expression is observed in many cancer cases. miR-515-5p is reported to be concerned with the course of many cancers. This study explores the role of miR-515-5p in proliferation and drug sensitivity of RB cells. Methods: Human RB cell lines (WERI-RB1, SO-RB50 and Y79) and human retinal pigment epithelial cell line ARPE-19 were utilized in this study. Drug-resistant cells SO-RB50/VCR and SO-RB50/CBP were constructed for the following experiments. The expressions of miR-515-5p and Notch1 in RB cells were detected. Notch1 was significantly upregulated in RB cells while miR-515-5p was notably downregulated. Then, the binding relationship between miR-515-5p and Notch1 was predicted and verified. Results: miR-515-5p negatively regulated Notch1 expression. In vitro and in vivo experiments revealed that overexpressed miR-515-5p inhibited RB cell proliferation and enhanced drug sensitivity. Functional rescue experiment suggested that miR-515-5p regulated RB cell proliferation and drug sensitivity via inhibiting Notch1 expression. Conclusion: It could be concluded that overexpressed miR-515-5p suppressed proliferation and drug resistance of RB cells by targeting Notch1 expression, indicating that miR-515-5p might constitute a promising therapy target for RB.Keywords
This publication has 47 references indexed in Scilit:
- MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expressionBiomedicine & Pharmacotherapy, 2016
- Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid TumorsCurrent Drug Metabolism, 2016
- Targeting of miR34a–NOTCH1 Axis Reduced Breast Cancer Stemness and ChemoresistanceCancer Research, 2014
- Intracardiac Echocardiography-Guided InterventionsJACC: Cardiovascular Interventions, 2014
- A novel retinoblastoma therapy from genomic and epigenetic analysesNature, 2012
- Bioenergetics Pathways and Therapeutic Resistance in Gliomas: Emerging Role of MitochondriaCurrent Pharmaceutical Design, 2011
- Epidemiology and Rb1 gene of retinoblastoma2011
- Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3Neuropathology and Applied Neurobiology, 2010
- RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancerOncology Reports, 2010
- Retinoblastoma2010